We invest in projects aimed at curing ultra-rare diseases
Core to the Foundation’s mission, we support research with a special focus on projects that have the clearest chance of reaching patients. We do this via two mechanisms: through our research grants and through the RTWCF Research Institute.
Science supporting people with rare diseases
We provide research grants to scientists and academics needing funding to continue their work. However, we aim to be far more than just funders of this work. We view our role as partners.
We visit leading academic institutions where cutting edge rare disease research is conducted. We source the research projects that are focused on direct impact to patients and have a focus on therapeutics. Then with our deep scientific and drug discovery expertise, we collaborate with these scientists to write a research grant proposal that will drive this science forward.
We’re collaborators, thought leaders, scientists, and drug hunters.
We fund academic projects with a particular interest in monogenetic diseases that affect fewer than 300 people worldwideUPDATE ME
Through our Research Institute we make financial, experimental, and intellectual contributions to advance the science we fundLearn more
Joe Katakowski Ph.D
The convergence of advances in genomics and innovations in genetic medicines have rendered previously intractable diseases treatable and, in some instances, curable. I’m honored to be a part of the RTW Charitable Foundation team seeking to extend the potential of genetic medicines to patients with ultra-rare disease.
We have a really unique and dynamic team focused on innovative solutions and forward thinking perspectives. We specialise in cutting edge therapies and programmes for rare and ultra-rare diseases.
The RTW Charitable Foundation was built on the belief that promising science should be explored. But in many cases, science that is too early in the development process or for patients few in numbers often does not get funding. But when we see science where there is a possibility of it developing a cure for a rare disease, it is one in which we can’t leave behind.
The NYU Pediatrics Undiagnosed Diseases Program
The NYU Pediatrics Undiagnosed Diseases Program applies novel genomics technologies to the care of children with rare diseases.
Many of the patients they serve are from low-income or immigrant families, which do not typically have access to basic genetic testing. Funding from RTWCF supported the program, led by Dr. Gilad Evrony, to offer families advanced genomic testing methods, including long-read sequencing, optical genome mapping, and RNA-sequencing.
The Global Diagnosis Network: Diversity Rare Undiagnosed Diseases Program
Led by Alan Shuldiner, MD at the Global Genomic Medicine Collaborative and Toni Pollin, MS, PhD, CGC at the University of Maryland School of Medicine, is a pilot program aimed at providing families in low- and middle-income countries with access to diagnostic testing for rare diseases.
Starting in Mexico, Malaysia, Sri Lanka, South Africa, Chile, and Nepal, RTWCF support is making it possible to provide clinics with the staff and equipment needed for exome sequencing, diagnostic testing, and genetic counseling.
Annual Report 2021
2021 was an important year for our team. Take a closer look at what we accomplished alongside our humanitarian and research partners in our first Annual Report.